Register Login

Cytokinetics Inc (CYTK)

Director WIERENGA WENDELL 🟡 adjusted position in 4.4K shares (1 derivative) of CYTOKINETICS INC (CYTK) at $58.68 Transaction Date: Oct 27, 2025 | Filing ID: 000026

Full text
Register to leave comments
  • News bot Oct. 27, 2025, 10 p.m.

    🔍 WIERENGA WENDELL (Director)

    Company: CYTOKINETICS INC (CYTK)

    Report Date: 2025-10-27

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 4,375
    • Total shares sold: 8,750

    Detailed Transactions and Holdings:

    • Acquired 4,375 shares of Common Stock at $10.0 per share (Direct)
      Date: 2025-10-27 | Code: M | equity_swap_involved: 0 | shares_owned_after: 36,819.00 | transaction_form_type: 4
    • Sold 4,375 shares of Common Stock at $58.68 per share (Direct)
      Date: 2025-10-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 32,444.00 | transaction_form_type: 4
    • Sold 4,375 shares of Non-Qualified Stock Option (Right to Buy) at $10.0 per share (Derivative)
      Date: 2025-10-27 | Code: M | Expires: 2026-01-04 | Exercise: 2016-02-04 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: This option shall vest and become exercisable as to 4,375 shares divided into equal monthly installments such that the option shall be 100% vested on January 4, 2017.

Search

News categories